论文部分内容阅读
目的 观察潘特生调节血脂的临床效果。方法 把120例经化验确诊为高脂血症的病人(男80例,女40例,平均年龄65.5岁),随机分为两组。潘特生治疗组70例,32例病人胆固醇(TC)及甘油三脂(TG)均增高,48例仅有TG增高,在饮食控制和适量运动的同时口服潘特生(黑龙江省豪康制药有限公司,生产批准文号:黑卫药准字1995第200009号)60mg,3/d,疗程3个月。烯康丸对照组50例,22例TC及TG均增高,28例仅TG增高,口服烯康丸2粒,3/d,也进行饮食控制及适量运动,疗程与潘特生治疗组相同。结果 潘特生治疗组在降低TC、TG与对照组有显著性差异,均无明显副作用。结论 潘特生降脂疗效是令人满意的,可以作为一种经济、安全的降血脂药物用于临床。
Objective To observe the clinical effect of Pantesen’s regulation of blood lipids. Methods A total of 120 patients diagnosed with hyperlipidemia by laboratory tests (80 males and 40 females, mean age 65.5 years) were randomly divided into two groups. Pantethen treatment group, 70 patients, 32 patients with cholesterol (TC) and triglyceride (TG) were increased in 48 cases, only TG increased in the diet and moderate exercise at the same time oral Pantesen (Heilongjiang Hao Pharmaceutical Co., Ltd., production approval number: Black Wei Yaozhun Zi No. 200009/2009) 60mg, 3 / d, treatment for 3 months. Decarban control group of 50 patients, 22 cases of TC and TG were increased, 28 cases of only elevated TG, oral pill 2, 3 / d, diet control and moderate exercise, the same course of treatment and Pantante treatment group. Results Pante Sheng treatment group in reducing TC, TG and the control group were significantly different, no significant side effects. Conclusions Pantet’s lipid-lowering efficacy is satisfactory and can be used clinically as an economical and safe hypolipidemic drug.